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INTRODUCTION
Most patients with head and neck cancer successfully receive 
oncologic resection followed by free or local flap reconstruction, 
depending on the tumor’s size and location [1,2]. Locoregional 
flaps, such as pectoralis major muscle island flaps or temporalis 
muscle flap transpositions, are widely used. In addition to local 
flaps, microvascular free flap surgery—with options including 
anterolateral thigh free flaps, radial forearm free flaps, and verti-
cal rectus abdominis myocutaneous free flaps—is also em-
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ployed because this technique can yield both cosmetic and 
functional reconstruction in one step [3]. With a flap failure rate 
of less than 5% at most institutions, surgical resection of the tu-
mor followed by reconstruction can be performed without an 
undue burden [4]. Despite effective curative resection and re-
construction, head and neck cancer patients face a high risk of 
recurrence [5,6]. In addition, patients with a history of head and 
neck cancer are at risk of a second primary cancer at a rate of 
5%–30% [7]. In these cases, surgeons inevitably choose addi-
tional treatments including operations. In these patients, the op-
timal treatment choice is considered to be sequential curative 
resection and reconstruction, just as in those with primary can-
cer [5]. Sequential reconstruction is defined as reconstruction 
following the resection of a recurrent tumor even though a pre-
vious reconstructive procedure was performed at the same site. 
However, due to a lack of recipient vessels, altered anatomy, risk 
of flap loss, and other complications, reasonable hesitation to 
perform sequential reconstructions often occurs before an addi-
tional operation [4,8,9]. Although these factors might negatively 
affect a secondary operation, few large-scale studies have inves-
tigated the operative outcomes of sequential reconstruction fol-
lowing recurrent head and neck cancer. Therefore, we conduct-
ed a retrospective review of sequential reconstructions per-
formed during a 10-year period at our institution. We sought to 
determine whether additional microvascular or locoregional re-
construction was the optimal treatment strategy. In this study, 
we evaluated the outcomes of sequential reconstructions for pa-
tients who experienced recurrent head and neck cancer and 
postoperative complications associated with reoperation. 
METHODS
A review of patients who experienced recurrent head and neck 
cancer followed by reconstruction with a locoregional flap or a 
free vascularized flap at our center between 2008 and 2017 was 
performed. Patients were included in our sample if they under-
went reconstruction following curative resection of recurrent 
head and neck cancer, regardless of the reconstruction method 
used during the first procedure. Additional reconstructions due 
to nonmalignant lesions were not included in our sample. Thus, 
only patients who underwent sequential curative resection of 
recurrent head and neck cancer followed by reconstruction were 
included in this study. 
Our review included 58 total patients who received sequential 
head and neck reconstructions. A retrospective review of their 
demographic characteristics and outcomes was carried out. We 
analyzed the cancer sites, amount of time until recurrence, pa-
thology, the initial and recurrent cancer stages, and any chemo-
therapy and radiotherapy that took place. The final reconstruc-
tion strategies were categorized as either a free flap or a local 
flap. In cases where a free vascularized flap was performed, mi-
cro-anastomosed arteries and veins were reconstituted. We also 
analyzed any postoperative complications. Continuous data are 
represented as mean ± standard deviation. 
RESULTS
A total of 457 patients underwent head and neck reconstruction 
following tumor resection. Among them, 58 patients underwent 
reconstruction following curative resection of recurrent head 
and neck cancer, including 43 males (74.1%) and 15 females 
(25.9%). The average follow-up period was 44.2 ± 39.4 months, 
with a range from 3 months to 143 months. Twenty-nine pa-
tients (50%) died during follow-up due to old age, other medi-
cal conditions, and tumor recurrence. The 1-year survival rate 
was 74.1% and the 5-year survival rate was 50%. The number of 
patients who died after being diagnosed with a local recurrent 
tumor or distant metastasis was 15 (25.9%). Fourteen patients 
(24.1%) died for other reasons, including old age, heart, lung 
disease, and intracranial hemorrhage. There were no cases of 
failed reconstruction following curative resection of recurrent 
head and neck cancer at our institution. Patients’ demographic 
characteristics, including tumor location, pathology, and stage, 
are listed in Table 1. The mean age of patients at the time of the 
initial operation was 55.4 ± 15.3 years, and the average age at the 
most recent procedure was 59.0 ± 14.3 years. The mean interval 
between operations was 49.2 ± 62.4 months. Twelve patients 
(20.7%) underwent surgery on the tongue, 12 patients (20.7%) 
on the oropharynx, nine patients (15.5%) on the oral cavity, and 
seven patients (12.1%) on the maxilla. The most common type 
of malignancy was squamous cell carcinoma, which was found 
in 43 patients (74.1%), followed by adenocarcinoma in eight 
patients (13.8%). At the time of the first operation, 19 patients 
(32.8%) had stage I malignancy, while 15 (25.9%) were diag-
nosed with stage IV malignancy. Upon recurrence, the largest 
number of patients had stage IV malignancy (24 patients; 
41.4%), followed by stage I malignancy (15 patients; 25.9%). 
Twelve patients (22.4%) underwent chemotherapy, while 29 
(50.0%) received radiotherapy. Twelve patients (20.7%) experi-
enced recurrence after sequential reconstruction, of whom two 
patients (3.4%) underwent local excision and nine patients 
(15.5%) died. Eight patients (13.8%) were diagnosed with dis-
tant metastasis, with metastatic sites including the bone, lung, 
brain and neck, of whom six patients (10.3%) died. Twenty pa-
tients (34.5%) underwent postoperative radiotherapy and 18 
patients (31.0%) underwent postoperative chemotherapy after 
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sequential reconstruction.
The different types of flaps are listed in Table 2. Eleven pa-
tients (19.0%) received two free flap procedures, and 10 pa-
tients (17.2%) underwent three or more total operations. Thir-
ty-four patients (58.6%) were treated using a sequential free flap 
reconstruction, while 24 patients (41.4%) received local flaps. 
An anterolateral thigh free flap was used for 11 patients (19.0%), 
followed by a radial forearm free flap in 10 patients (17.2%) and 
a rectus abdominis free flap in six patients (10.3%). A pectoralis 
major flap was used for 14 patients (24.1%), while five (8.6%) 
were treated with a temporalis muscle flap. 
In patients who received a free flap, the superficial thyroid ar-
tery was most commonly chosen for arterial micro-anastomosis 
(26 patients; 76.5%), and a branch of the internal jugular vein 
was the most common site for micro-anastomosis of a vein (19 
patients; 55.9%) (Table 3). The facial artery, lingual artery, 
transverse cervical artery and superior thyroid vein, external 
jugular vein, facial vein, and transverse cervical vein were also 
used for micro-anastomoses. All anastomoses but one were con-
ducted in an end-to-end fashion; in one case, the vein was anas-
tomosed in an end-to-end fashion with a radial forearm free flap. 
In total, 13 complications occurred. In two patients (3.45%), 
re-exploration was performed within 1 week of the reconstruc-
tion; in another two patients (3.45%), re-exploration took place 
after 1 week. Although partial flap loss was noted in two patients 
(3.45%), there were no total losses of any flaps. There was also 
one case of hematoma (1.72%) and four cases that required mi-
nor revisions (6.90%) (Table 4).
Patients’ swallowing and speech abilities were evaluated at an 
outpatient clinic. Seventeen patients (29.3%) who underwent 
reconstruction of the extra-oropharynx region, such as the 
Characteristics Value
No. of patients 58
Sex
   Male 43 (74.13)
   Female 15 (25.86)
Age at initial operation (yr) 55.40±15.27
Age at sequential operation (yr) 59.04±14.29
Term between operations (mon) 49.2±62.4
Follow-up period (mon) 44.2±39.4
Reconstruction sites
   Tongue 12 (20.69)
   Oropharynx 12 (20.69)
   Oral cavity 9 (15.52)
   Maxilla 7 (12.07)
   Hypopharynx 5 (8.62)
   Parotid gland 5 (8.62)
   External auditory canal 3 (5.17)
   Skin 2 (3.45)
   Lacrimal gland 2 (3.45)
   Mandible 1 (1.72)
Pathology
   Squamous cell carcinoma 43 (74.13)
   Adenocarcinoma 8 (13.79)
   Mucoepidermoid carcinoma 2 (3.45)
   Pleomorphic carcinoma 2 (3.45)
   Malignant melanoma 1 (1.72)
   Basal cell carcinoma 1 (1.72)
   Myoepithelial carcinoma 1 (1.72)
Initial stage
   I 19 (32.76)
   II 11 (18.97)
   III 13 (22.41)
   IV 15 (25.86)
Recurrent stage
   I 15 (25.86)
   II 6 (10.34)
   III 13 (22.41)
   IV 24 (41.38)
Chemotherapy 12 (20.69)
Radiotherapy 29 (50.00)
≥2 Free flaps 11 (18.97)
≥3 Operations 10 (17.24)
Values are presented as number (%) or mean±SD.
Table 1. Patient characteristics 
Flap No. (%)
Free flap 34 (58.62)
   Anterolateral thigh 11 (18.97)
   Radial forearm 10 (17.24)
   Rectus abdominis 6 (10.34)
   Vastus lateralis 3 (5.17)
   Latissimus dorsi 2 (3.45)
   Fibula 2 (3.45)
Local flap 24 (41.38)
   Pectoralis major 14 (24.14)
   Temporalis 5 (8.62)
   Tongue 2 (3.45)
   Palate 2 (3.45)
   Latissimus dorsi 1 (1.72)
Table 2. Types of flaps used
Vessel No. (%)
Artery
   Superior thyroid  26 (76.47)
   Facial  4 (11.76)
   Lingual 3 (8.82)
   Transverse cervical 1 (2.94)
Vein
   Branch of IJV 19 (55.88)
   Superior thyroid 6 (17.65)
   EJV 4 (11.76)
   Facial 4 (11.76)
   Transverse cervical 1 (2.94)
IJV, internal jugular vein; EJV, external jugular vein.
Table 3. Micro-anastomosis recipient vessels (n=34)
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cheek, ear, and forehead, had undisrupted swallowing and 
speech and were not examined. In addition, eight patients 
(13.8%) died before the examination. Of the rest of the patients, 
12 (20.7%) were able to ingest solid meals, 14 (24.1%) ate only 
soft meals, and seven (12.1%) could not eat anything. With re-
gard to speech, eight patients (13.8%) had normal speech, 11 
(19.0%) had an impediment, and 14 (24.1%) were unable to 
speak.
DISCUSSION
This study presents a thorough investigation of reconstruction 
procedures for recurrent head and neck cancer involving 58 pa-
tients during a period of 10 years. At our institution, 26 patients 
required subsequent repetitive reconstructive surgery. Eleven 
patients received a subsequent free vascularized flap, while 10 
patients underwent three or more reconstructive operations. 
These subsequent reconstructive procedures were more chal-
lenging than the initial operation due to scarring from the first 
operation, fibrosis caused by radiation, and other structural 
changes that hindered the surgeon in cases with difficult anato-
my [10]. Nonetheless, no patient experienced total flap loss. 
Our experience suggests that sequential reconstructive surgery 
is worth considering for recurrent head and neck cancer pa-
tients, even if they have undergone prior reconstructions, such 
as local and free vascularized flaps. These findings should aid 
oncologists in the selection of treatment strategies, including 
wide surgical removal, when patients experience tumor recur-
rence.
In our study, 24 patients (41.4%) underwent reconstruction 
using a locoregional flap. A pectoralis major flap was mostly pre-
ferred (14 cases; 24.1%). Some studies have suggested that in 
appropriate surgical locations and in cases with contraindica-
tions for microvascular surgery, a pectoralis major flap should 
still be considered for head and neck reconstruction despite the 
current trend toward microvascular reconstruction [11-13]. 
Other types of locoregional flaps have also been used, such as a 
temporalis muscle flap or a palatal flap. However, considering 
the location and size of the defect following a wide tumor resec-
tion, a pectoralis major flap was the most adequate locoregional 
flap. In another study, the authors suggested that a trapezius is-
land myocutaneous flap was also a suitable option for head and 
neck reconstruction [14]. However, our surgeons did not use 
this technique; moreover, most of them preferred free flaps, 
such as an anterolateral thigh free flap, which was used in 11 cas-
es (20.0%), followed by a radial forearm free flap in 10 cases 
(17.2%). In general, the length or diameter of the pedicle of an 
anterolateral thigh flap and a radial forearm flap are known to be 
adequate for head and neck reconstructions [10,15-17]. In this 
study, the choice of flap to use in a patient with recurrent cancer 
was the same as that in a primary cancer case. 
Out of 34 free flap cases, the superficial temporal artery was 
used in 26 cases (76.47%), and a branch of the internal jugular 
vein was employed in 19 cases (55.88%) for micro-anastomo-
ses. Even in patients who underwent repeated reconstruction, 
no flap loss was noted. In some studies, repeated free flap proce-
dures were successfully performed by re-using the same vessels 
as the prior operation, and no flap failures occurred [10,18]. Ac-
cording to our study, the use of familiar vessels yields positive 
outcomes, even when structural changes are present due to pri-
or radiation or reconstruction. 
In a previous study, several episodes of microvascular recon-
struction were associated with postoperative complications, 
such as a longer hospital stay, total flap failure, fistula, infection, 
and anastomosis thrombosis [19]. In the current study, postop-
erative complications were noted in 13 cases (22.4%). Total re-
explorations were performed in four cases (6.90%). Of these 
cases, two (3.45%) occurred within 1 week, which may suggest 
thrombosis or technical factors such as the micro-anastomosis 
technique used. However, no flap became detached. In every 
case, appropriate patient-oriented judgment was required to de-
termine the best treatment. The seven patients with impaired 
swallowing ability and 14 patients with impaired speech ability 
presented similar results to those of the prior assessment after 
primary reconstruction.
Our study had several limitations. First, the study was a retro-
spective review performed at a single institution that was entire-
ly dependent on medical records. Second, since some cases 
were so recent, the overall long-term survival rate was not avail-
able. Patients who experience recurrent head and neck cancer 
are considered to have a poor prognosis, so further investiga-
tions should be carried out in the future. Third, although the 
surgeons at our institution are sufficiently qualified to perform 
several reconstructive operations, their choice of flaps was limit-
ed. We did not use relatively unfamiliar flaps, such as trapezius 
island myocutaneous flaps or superficial circumflex iliac artery 
perforator free flaps.
The oncologic prognosis for recurrent head and neck cancer 
Complications No. (%)
Re-exploration within 1 week 2 (3.45)
Total re-exploration 4 (6.90)
Partial flap loss 2 (3.45)
Hematoma 1 (1.72)
Minor revision 4 (6.90)
Table 4. Postoperative complications
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has gradually improved, and patients are expected to live longer 
than before [20]. As the long-term survival rate increases in 
these patients, it will be necessary to strongly recommend per-
forming reconstructive surgery to obtain satisfactory results 
compared to those produced by conservative care [21-23].
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